{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:48:57Z","timestamp":1772120937451,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31670931"],"award-info":[{"award-number":["31670931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.intimp.2019.106013","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:44:27Z","timestamp":1575283467000},"page":"106013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine"],"prefix":"10.1016","volume":"78","author":[{"given":"Ya","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhai","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.106013_b0005","unstructured":"FAO, H7N9 situation update, 2019. <http:\/\/www.fao.org\/ag\/againfo\/programmes\/en\/empres\/h7n9\/situation_update.html>."},{"key":"10.1016\/j.intimp.2019.106013_b0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann. NY Acad. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2019.106013_b0015","doi-asserted-by":"crossref","first-page":"950","DOI":"10.4161\/hv.24939","article-title":"Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design","volume":"9","author":"De Groot","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"4","key":"10.1016\/j.intimp.2019.106013_b0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3201\/eid2404.171995","article-title":"Influenza A(H7N9) virus antibody responses in survivors 1 year after infection, China, 2017","volume":"24","author":"Ma","year":"2018","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2019.106013_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1099\/jgv.0.000365","article-title":"Putative suppressing effect of IgG Fc-conjugated haemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines","volume":"97","author":"He","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.intimp.2019.106013_b0030","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3389\/fmicb.2017.01898","article-title":"Antibody immunity induced by H7N9 avian influenza vaccines: Evaluation criteria, affecting factors, and implications for rational vaccine design","volume":"8","author":"Hu","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2019.106013_b0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2014.03.008","article-title":"Immunosenescence: influenza vaccination and the elderly","volume":"29","author":"Haq","year":"2014","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106013_b0040","doi-asserted-by":"crossref","first-page":"e0150678","DOI":"10.1371\/journal.pone.0150678","article-title":"Immunopotentiation of different adjuvants on humoral and cellular immune responses induced by HA1-2 subunit vaccines of H7N9 influenza in mice","volume":"11","author":"Song","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2019.106013_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13346-012-0085-z","article-title":"Strategies for intranasal delivery of vaccines","volume":"3","author":"Zaman","year":"2013","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.intimp.2019.106013_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/imr.12662","article-title":"CD4 T cells in protection from influenza virus: viral antigen specificity and functional potential","volume":"284","author":"Sant","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2019.106013_b0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/08820131003674826","article-title":"Induction of cell-mediated immune responses to peptide antigens of P. vivax in microparticles using intranasal immunization","author":"Bhat","year":"2010","journal-title":"Immunol. Invest. 39(4\u20135)"},{"issue":"48","key":"10.1016\/j.intimp.2019.106013_b0060","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.vaccine.2014.06.065","article-title":"Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer","volume":"32","author":"Scheiermann","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2019.106013_b0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert. Rev. Vac."},{"issue":"34","key":"10.1016\/j.intimp.2019.106013_b0070","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1016\/j.vaccine.2011.05.087","article-title":"Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2019.106013_b0075","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fimmu.2018.00320","article-title":"Host immune response to influenza a virus infection","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2019.106013_b0080","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1128\/JVI.75.11.5416-5420.2001","article-title":"Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice","volume":"75","author":"Liang","year":"2001","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106013_b0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/21645515.2017.1423156","article-title":"Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats","volume":"14","author":"Zhou","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.intimp.2019.106013_b0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/jcm.23.1.66-72.1986","article-title":"Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine","volume":"23","author":"Clements","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.intimp.2019.106013_b0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fimmu.2017.00326","article-title":"Mucosal and systemic immune responses to influenza H7N9 antigen HA1\u20132 Co-delivered intranasally with flagellin or polyethyleneimine in mice and chickens","volume":"8","author":"Song","year":"2017","journal-title":"Front. Immunol."},{"issue":"20\u201322","key":"10.1016\/j.intimp.2019.106013_b0100","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/S0264-410X(00)00556-9","article-title":"Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA-or IgG-mediated protective mucosal immunity","volume":"19","author":"de Haan","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2019.106013_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0133-y","article-title":"Systemic and mucosal humoral immune responses induced by the JY-adjuvanted nasal spray H7N9 vaccine in mice","volume":"7","author":"Xu","year":"2018","journal-title":"Emerg. Microbes Infect."},{"issue":"3","key":"10.1016\/j.intimp.2019.106013_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J. Biol. Stand."},{"issue":"9","key":"10.1016\/j.intimp.2019.106013_b0115","doi-asserted-by":"crossref","first-page":"e107638","DOI":"10.1371\/journal.pone.0107638","article-title":"Sortase A induces Th17-mediated and antibody-independent immunity to heterologous serotypes of group A streptococci","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.intimp.2019.106013_b0120","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2019.106013_b0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2013.11.036","article-title":"One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge","volume":"32","author":"Klausberger","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2019.106013_b0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/JVI.02390-14","article-title":"Assessment of the internal genes of influenza A (H7N9) virus contributing to high pathogenicity in mice","volume":"89","author":"Bi","year":"2015","journal-title":"J. Virol."},{"issue":"40","key":"10.1016\/j.intimp.2019.106013_b0135","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","article-title":"Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.intimp.2019.106013_b0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.intimp.2019.106013_b0145","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/IAI.74.5.2760-2766.2006","article-title":"In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii","volume":"74","author":"Medaglini","year":"2006","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.intimp.2019.106013_b0150","doi-asserted-by":"crossref","first-page":"e0203678","DOI":"10.1371\/journal.pone.0203678","article-title":"Protective immune mechanisms of Yifei Tongluo, a Chinese herb formulation, in the treatment of mycobacterial infection","volume":"13","author":"Fan","year":"2018","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.intimp.2019.106013_b0155","first-page":"644","article-title":"Toll-like receptors 2 and 4-mediated reciprocal Th17 and antibody responses to group A streptococcus infection","volume":"215","author":"Wang","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"6155","key":"10.1016\/j.intimp.2019.106013_b0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.1242917","article-title":"Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses","volume":"342","author":"Shi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.intimp.2019.106013_b0165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijbiomac.2018.07.141","article-title":"Boosting half-life and effector functions of therapeutic antibodies by Fc-engineering: an interaction-function review","author":"Fonseca","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106013_b0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.immuni.2015.06.016","article-title":"Long-Lived plasma cells are contained within the CD19(-)CD38(hi)CD138(+) subset in human bone marrow","volume":"43","author":"Halliley","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2019.106013_b0175","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7883\/yoken.JJID.2004.236","article-title":"Defense mechanisms against influenza virus infection in the respiratory tract mucosa","volume":"57","author":"Tamura","year":"2004","journal-title":"Jpn. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2019.106013_b0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2019.106013_b0185","doi-asserted-by":"crossref","unstructured":"R.D. Weeratna, C.L. Brazolot Millan, M.J. McCluskie, H.L. Davis, CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice, FEMS Immunol. Med. Microbiol. 32(1) (2001) 65\u201371. https:\/\/doi.org\/10.1111\/j.1574-695X.2001.tb00535.x.","DOI":"10.1111\/j.1574-695X.2001.tb00535.x"},{"issue":"5","key":"10.1016\/j.intimp.2019.106013_b0190","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.162.5.2530","article-title":"Mucosal immunity to influenza without IgA: an IgA knockout mouse model","volume":"162","author":"Mbawuike","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.106013_b0195","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3389\/fmicb.2017.00900","article-title":"Nasal IgA provides protection against human influenza challenge in volunteers with low serum influenza antibody titre","volume":"8","author":"Gould","year":"2017","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106013_b0200","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2019.106013_b0205","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/JVI.03099-14","article-title":"Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones","volume":"89","author":"He","year":"2015","journal-title":"J. Virol."},{"issue":"54","key":"10.1016\/j.intimp.2019.106013_b0210","doi-asserted-by":"crossref","first-page":"91828","DOI":"10.18632\/oncotarget.20064","article-title":"Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB\/c mice","volume":"8","author":"Ou","year":"2017","journal-title":"Oncotarget"},{"issue":"35","key":"10.1016\/j.intimp.2019.106013_b0215","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1016\/j.vaccine.2014.06.016","article-title":"A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets","volume":"32","author":"Wong","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.intimp.2019.106013_b0220","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.intimp.2019.106013_b0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.virol.2017.08.016","article-title":"An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge","volume":"511","author":"Wilson","year":"2017","journal-title":"Virology (Lond)"},{"key":"10.1016\/j.intimp.2019.106013_b0230","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2018.03.025","article-title":"Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness","volume":"53","author":"Eichelberger","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2019.106013_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.08.008","article-title":"Protection against influenza H7N9 virus challenge with a recombinant NP-M1-HSP60 protein vaccine construct in BALB\/c mice","volume":"111","author":"Yang","year":"2014","journal-title":"Antiviral. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919318880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919318880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:17:37Z","timestamp":1761585457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919318880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"alternative-id":["S1567576919318880"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737044048.793573741","asserted-by":"object"}]},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106013"}}